Current Report Filing (8-k)

0001096938false00010969382021-10-142021-10-14iso4217:USDxbrli:sharesiso4217:USDxbrli:shares

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): October 14, 2021

 

UNITED HEALTH PRODUCTS, INC.

(Exact name of registrant as specified in its charter)

 

Nevada		000-27781		84-1517723
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

 

10624 S. Eastern Ave., Ste. A209 Henderson, NV 89052

(Address of Principal Executive Offices) (Zip Code)

 

[phone]

Registrant’s telephone number, including area code

 

___________________________________________________ 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). 

 

Emerging Growth Company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
N/A		N/A		N/A

 

 

Item 7.01. Regulation FD Disclosure and Other Events.

   

On October 7, 2021, United Health Products, Inc. (the “Company”) issued a press release providing a business update along with the announcement of an investor information session scheduled for 9:00am Eastern Time on October 15, 2021.  A copy of the press release is being furnished herewith as Exhibit 99.1,

 

During the investor information session, the Company will be making an investor presentation, a copy of which is being furnished herewith as Exhibit 99.2.

 

Investors wishing to participate in the information session may register by emailing the Company at [e-mail] with the name, email address, phone number and country of residency of the participant.

    

Item 9.01. Financial Statements and Exhibits. 

 

(d) Exhibits

 

Exhibit Number		Description
99.1		Press release, dated October 7, 2021
99.2		Investor Presentation
104		Cover Page Interactive Data File (formatted as Inline XBRL)

 

2

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized, on October 14, 2021.

 

	United Health Products, Inc.
	By:	/s/ Brian Thom
		Brian Thom Principal Executive Officer

 

	By:	/s/ Kristofer Heaton
		Kristofer Heaton
		Principal Financial Officer

 

3